Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Rakan Ghubej
Hub - Paul Hastings LLP
NAVIGATING NEW PATHS TO GROWTH In today’s world of transformative change, our purpose is clear — to help our clients and people navigate new paths to growth. Our innovative approach and unmatched client service has helped guide our journey to becoming one of the world’s leading global law firms in such a short time. Founded in 1951, Paul Hastings has grown strategically to anticipate and respond to our clients needs’ in markets across the globe.
Clock is Ticking: 1-Year until DSCSA’s Enhanced Drug Distribution Security Requirements Take Effect | JD Supra
Ten years in the making, and full implementation is finally coming.
FDA Finalizes ‘Instructions for Use’ Guidance on Patient Labeling for Drugs and Biologics | JD Supra
October 5, 2022 Henry Finkelstein, Rakan Ghubej, Peter Lindsay Paul Hastings LLP + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: [co-author:Hanna Ali] As companies begin planning for the upcoming year, attorneys who sit on promotional review committees should consider the significant guidance published by the U.S. Food and Drug Administration (“FDA”) and update process aids and related trainings.
Buyers Take Note: OIG Opinion Provides Insights on Physician-Owned Entities & Their Technologies | JD Supra
Part I On April 20, 2022, the Office of Inspector General (“OIG”) of the Department of Health and Human Services (“HHS”) issued Advisory Opinion, No. 22-07 (“Opinion 22-07”), an informative opinion regarding arrangements whereby physicians have an ownership interest in a medical device company that manufactures products that the physicians—with ownership interests—or their close family members can order or utilize.
Buyers Take Note: OIG Opinion Provides Insights on Physician-Owned Entities & Their Technologies
Part I On April 20, 2022, the Office of Inspector General (“OIG”) of the Department of Health and Human Services (“HHS”) issued Advisory Opinion, No. 22-07 (“Opinion 22-07”), an informative opinion regarding arrangements whereby physicians have an ownership interest in a medical device company that manufactures products that the physicians—with ownership interests—or their close family members can order or utilize.
Compliance Lessons From DOJ's Merit Medical Settlement
Law360 (November 3, 2020, 5:36 PM EST) -- On Oct.14, the U.S. Department of Justice announced a settlement agreement with Utah-based medical device manufacturer, Merit Medical Systems Inc., to resolve alleged violations of the federal Anti-Kickback Statute and False Claims Act and numerous state false claims act statutes. These allegations stem from a complaint filed by Merit's former chief compliance officer, who filed a qui tam action in April 2016. Merit denied the allegations.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rakan
Contact Rakan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack